PATENT CLAIM ANALYSIS

Application Number: 16148546
Application Type: Utility
Filing Date: 2018-10
Publication Date: 2019-06
Patent Classification: ["514", "529000"]

Abstract:
This invention provides methods of enhancing brain development; increasing or enhancing intelligence; increasing or enhancing synthesis and levels of phospholipids, synapses, synaptic proteins, and synaptic membranes by a neural cell or brain cell, comprising contacting a subject or a pregnant or nursing mother thereof with a composition comprising an omega-3 fatty acid, an omega-6 fatty acid, and/or uridine, a metabolic precursor thereof, or a combination thereof.

Claim (Index 8):
A method of improving or enhancing the intelligence of a subject in need thereof comprising administering to said subject a composition comprising:\n (a) eicosapentaenoic acid; (b) uridine, an acyl derivative thereof, a uridine phosphate or a CDP-choline, and (c) choline salt, wherein the choline salt is choline chloride, choline bitartrate or choline stearate, and the composition has about 200 mg to 800 mg of uridine, an acyl derivative thereof, a uridine phosphate or a CDP-choline and about 200 mg to 800 mg of the choline salt.

Metadata:
- Claim Count in Document: 29.0
- Percentile: 97.0
- Lexical Diversity: 1.71111
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['11920915', '11920914', '11341912', '10972777', '14005098']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7823309695399608
- 35 USC 102 Novelty (BERT): 0.6305087088510444
- Combined Prediction Score: 0.7671487434710692
- Mean Citation Score: 426.18414
- Max Citation Score: 600.16364
- Similarity Product: 551.067688240738

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test